AI
YCBD icon

AXS Investments’s cbdMD YCBD Stock Holding History

AXS Investments’s Portfolio YCBD Stock Details YCBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,401
Closed -$94.9K – 430
2023
Q4 		$94.9K Buy
11,401
+3,378
+42% +$21.2K 0.02% 333
2023
Q3 		$66.4K Buy
8,023
+3,367
+72% +$34.5K 0.02% 332
2023
Q2 		$52.1K Sell
4,656
-725
-13% -$19K 0.01% 346
2023
Q1 		$378K Buy
+5,381
New +$499K 0.12% 189

Other funds holding YCBD

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

AXS Investments's YCBD Position: Q1 2024 in Review

AXS Investments sold out of cbdMD (YCBD) in Q1 2024, closing a stake of 11,401 shares — an estimated $94.9K sold.

AXS Investments first reported a position in YCBD in Q1 2023 and held it in 4 quarters. The position peaked at $378K in Q1 2023. 19 funds tracked by Wall St. Rank hold YCBD as of Q1 2024.

  • AXS Investments reported no remaining cbdMD position as of Q1 2024 after selling out during the quarter.
  • AXS Investments sold 11,401 cbdMD shares in Q1 2024, an estimated $94.9K.
  • AXS Investments first reported a position in cbdMD in Q1 2023 and held it in 4 quarters.
  • AXS Investments's cbdMD position peaked at $378K in Q1 2023.
  • 19 funds tracked by Wall St. Rank held cbdMD as of Q1 2024.

Based on AXS Investments's 13F filing for Q1 2024, filed 13 May 2024.